Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline-containing quadruple therapy versus tailored therapy for rescue treatment of Helicobacter pylori infection
ChiCTR-TRC-13003975Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of minocycline in Helicobacter pylori infection (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Eradication rate. Started Jan 2014; status: completed.
02
Drugs
minocycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR-TRC-13003975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003975.